Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Summary

This pilot early phase I trial studies the side effects of vaccine therapy in treating patients with glioblastoma that has come back. Vaccines made from a person's white blood cells mixed with tumor proteins from another person's glioblastoma tumors may help the body build an effective immune response to kill tumor cells. Giving vaccine therapy may work better in treating patients with glioblastoma.

Timeline

Start

2013-11-27

Primary completion

2021-06-02

Completion

2021-06-02

Drugs

Indications